Literature DB >> 16762595

Intact T cell responses in ataxia telangiectasia.

Farzana Pashankar1, Vibha Singhal, Ike Akabogu, Richard A Gatti, Frederick D Goldman.   

Abstract

Ataxia telangiectasia (A-T) is an autosomal recessive multisystem disorder associated with a variable immune deficiency. The mechanism for this remains unclear. Qualitative and quantitative defects of cellular immunity have been previously reported. However, despite laboratory evidence of significant immune abnormalities, opportunistic infections are uncommon. To address this discrepancy, we analyzed cytokine production by quantitative real-time PCR and T cell function at the single cell level by flow cytometry in four A-T patients. CD4 and CD8 T cell subsets from these patients displayed intact signaling in response to anti-CD3 stimulation, similar to controls. Stimulated T cells from A-T patients also produced normal to increased levels of Th1 (IL-2, IFN-gamma) and Th2 (IL-10, IL-4) cytokines, relative to control values. Our results suggest that T cells from A-T patients may be more functionally intact than previously observed. This helps to explain the paucity of opportunistic infections encountered, unlike that encountered in other primary immunodeficiencies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16762595     DOI: 10.1016/j.clim.2006.04.568

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  9 in total

1.  Early and late extensive chronic graft-versus-host disease in children is characterized by different Th1/Th2 cytokine profiles: findings of the Children's Oncology Group Study ASCT0031.

Authors:  Jacob Rozmus; Kirk R Schultz; Kristin Wynne; Amina Kariminia; Preeti Satyanarayana; Mark Krailo; Stephan A Grupp; Andrew L Gilman; Frederick D Goldman
Journal:  Biol Blood Marrow Transplant       Date:  2011-05-25       Impact factor: 5.742

2.  Aberrant CD8+ T-cell responses and memory differentiation upon viral infection of an ataxia-telangiectasia mouse model driven by hyper-activated Akt and mTORC1 signaling.

Authors:  Anthony D D'Souza; Ian A Parish; Sharen E McKay; Susan M Kaech; Gerald S Shadel
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

3.  Immune deficiency in Ataxia-Telangiectasia: a longitudinal study of 44 patients.

Authors:  C Chopra; G Davies; M Taylor; M Anderson; S Bainbridge; P Tighe; E M McDermott
Journal:  Clin Exp Immunol       Date:  2014-05       Impact factor: 4.330

4.  A proposed bailout for A-T patients?

Authors:  Richard A Gatti; Susan Perlman
Journal:  Eur J Neurol       Date:  2009-06       Impact factor: 6.089

5.  Immunodeficiency, radiosensitivity, and the XCIND syndrome.

Authors:  Richard A Gatti; Elena Boder; Robert A Good
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

6.  Immunodeficiency in ataxia telangiectasia is correlated strongly with the presence of two null mutations in the ataxia telangiectasia mutated gene.

Authors:  E R Staples; E M McDermott; A Reiman; P J Byrd; S Ritchie; A M R Taylor; E G Davies
Journal:  Clin Exp Immunol       Date:  2008-05-26       Impact factor: 4.330

7.  Ataxia-telangiectasia mutated is required for the development of protective immune memory after influenza A virus infection.

Authors:  Rachel Warren; William Domm; Min Yee; Andrew Campbell; Jane Malone; Terry Wright; Margot Mayer-Pröschel; Michael A O'Reilly
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-09-11       Impact factor: 5.464

8.  T Cell Repertoire Abnormality in Immunodeficiency Patients with DNA Repair and Methylation Defects.

Authors:  Mingyan Fang; Zheng Su; Hassan Abolhassani; Wei Zhang; Chongyi Jiang; Bochen Cheng; Lihua Luo; Jinghua Wu; Shiyu Wang; Liya Lin; Xie Wang; Longlong Wang; Asghar Aghamohammadi; Tao Li; Xiuqing Zhang; Lennart Hammarström; Xiao Liu
Journal:  J Clin Immunol       Date:  2021-11-25       Impact factor: 8.317

Review 9.  Epstein-Barr Virus (EBV)-Related Lymphoproliferative Disorders in Ataxia Telangiectasia: Does ATM Regulate EBV Life Cycle?

Authors:  Moussab Tatfi; Olivier Hermine; Felipe Suarez
Journal:  Front Immunol       Date:  2019-01-04       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.